https://doi.org/10.55788/cb382c0a
The longitudinal cohort study involved 63 new diagnoses of EoE [1]. Patients aged 5 to 18 years completed the Pediatric Quality of Life Inventory (PedsQL) questionnaire on the day of their endoscopy. Parents of children aged 0 to 18 years also completed a parent-proxy PesQL, concerning their child. In this questionnaire, higher scores indicate a better health-related QoL. Different PedsQL versions were administered according to age groups: babies (0–4 years), kids (5–7 years), youths (8–12 years), and teenagers (13–18 years).The primary endpoints of the study were the total QoL scores, analysed by age at diagnosis and compared between self-reports and parent-proxy reports.
The study included 71% boys with a median age of 13 years. The median PedsQL scores were similar between self-reports and parent-proxy reports (84.8 vs 84.5). Both parents and children reported higher scores in physical health and social dimensions, and lower scores in emotional and school dimensions. Parents of teenagers assigned significantly higher psychosocial scores to their teenagers compared with parents of younger children (P=0.03). In the social dimension, by parent proxy, teenagers scored a median of 100, significantly higher than babies (P=0.04), kids (P=0.01), and youths (P=0.04) (see Figure). These differences were noted only in the parent evaluations. Self-reported scores remained similar across age groups.
Figure: PedsQL’s social dimension score by age for parent-proxy and child’s self-report [1]

SR, self-report; PP, parent-proxy.
The study thus reveals a different perception of QoL between parents and children, with parents of teenagers generally reporting higher QoL, particularly in the social dimension. These findings underscore the importance of considering both child and parent perspectives in QoL assessments.
- L'Heureux-Hubert E, et al. Quality of life of children newly diagnosed with eosinophilic esophagitis: a prospective cohort study. Sa1291, DDW 2024, 18–21 May, Washington, DC, USA.
Copyright ©2024 Medicom Medical Publishers
Posted on
Previous Article
« Gut permeability and neuroinflammation linked in Parkinson’s disease Next Article
Dupilumab shows promising results in treating paediatric eosinophilic oesophagitis »
« Gut permeability and neuroinflammation linked in Parkinson’s disease Next Article
Dupilumab shows promising results in treating paediatric eosinophilic oesophagitis »
Table of Contents: DDW 2024
Featured articles
PREEMPT CRC: Blood-based screening test for colorectal cancer shows promise
Eosinophilic Oesophagitis Treatments and Outcomes
Mepolizumab improves the histologic severity of eosinophilic oesophagitis
Budesonide demonstrates efficacy in eosinophilic oesophagitis
Dupilumab shows promising results in treating paediatric eosinophilic oesophagitis
Quality-of-life assessment in children with eosinophilic oesophagitis
Gut-Brain Axis and Neurological Disorders
Gut permeability and neuroinflammation linked in Parkinson’s disease
Cardiovascular and Metabolic Health Innovations
Promising data for cardiovascular outcomes of bariatric surgery in patients with obesity
Inflammatory Bowel Disease Therapies
GALAXI 2 & 3: Guselkumab proves efficacy in Crohn’s disease
QUASAR maintenance study: Guselkumab effective and safe for UC
VEDOKIDS: Vedolizumab maintains remission in patients with paediatric IBD
ADMIRE-CD II: Darvadstrocel does not meet primary endpoint in complex Crohn’s perianal fistulas
Advances in Endoscopy and Screening Techniques
PREEMPT CRC: Blood-based screening test for colorectal cancer shows promise
New cable-transmission capsule endoscopy shows high accuracy in detecting upper GI lesions
Liver and Biliary Tract Diseases Updates
Superior OS with atezolizumab plus bevacizumab versus lenvatinib in unresectable HCC
Nutritional consultation boosts nutritional status in patients with alcohol-associated hepatitis
REGENERATE study: Obeticholic acid shows antifibrotic benefit in NASH
Acalculous cholecystitis as a risk factor for gallbladder perforation: insights from a 10-year retrospective study
Other Gastrointestinal Diseases
STARS: Apraglutide shows efficacy in short bowel syndrome with intestinal failure
COX-2 inhibitors show promise in reducing severity of acute pancreatitis
Hormone-containing therapies may increase the risk of IBS and functional dyspepsia
Related Articles


November 26, 2021
A pragmatic guide to the updated IBS guidelines
November 2, 2020
Sustained response to faecal microbiota transplantation
© 2024 Medicom Medical Publishers. All rights reserved. Terms and Conditions | Privacy Policy
HEAD OFFICE
Laarderhoogtweg 25
1101 EB Amsterdam
The Netherlands
T: +31 85 4012 560
E: publishers@medicom-publishers.com